The Makona Variant of Ebola Virus Is Highly Lethal to Immunocompromised Mice and Immunocompetent Ferrets

Authors:

Abstract
During 2013–2016, a novel isolate of Ebola virus (EBOV-Makona) caused an epidemic in West Africa. The virus was distinct from known EBOV strains (EBOV-Kikwit and EBOV-Mayinga), which were responsible for previous outbreaks in Central Africa. To investigate the pathogenicity of EBOV-Makona, we engineered and rescued an early isolate (H.sapiens-wt/GIN/2014/Makona-Gueckedou-C07, called rgEBOV-C07) using an updated reverse-genetics system. rgEBOV-C07 was found to be highly pathogenic in both the knockout mouse and ferret models, with median lethal dose values of 0.078 and 0.015 plaque-forming units, respectively. Therefore, these animals are appropriate for screening potential countermeasures against EBOV-Makona without the need for species adaptation.
Funding Information
  • National Key Research and Development Program of China (2016YFE0205800)
  • National Key Program for Infectious Disease of China (2016ZX10004222)
  • Public Health Agency of Canada
  • National Institutes of Health (U19AI109762-1)
  • Canadian Institutes of Health Research (IER-143487)
  • Sanming Project of Medicine in Shenzen Municipality (ZDSYS201504301534057)
  • Shenzhen Science and Technology Research and Development Project (JCYJ20160427151920801)
  • National Natural Science Foundation of China International Cooperation and Exchange Program (816110193)

This publication has 13 references indexed in Scilit: